DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
Four weekly injections in a single dial-a-dose device, all six strengths. Here is how it actually works, what it costs on every rail — and the detail that suddenly matters most: it is the only form of Zepbound that Medicare's $50 GLP‑1 Bridge will pay for.
| Form | What it is | Self-pay | Medicare Bridge? |
|---|---|---|---|
| KwikPen (multi-dose) | 4 weekly doses per pen, dial-a-dose, needles separate | ~$299–$449/mo | YES — the only one |
| Single-dose pen | One auto-injection per pen, 4 pens/month, needle built in | List-price tier | No |
| LillyDirect vials | Draw up each dose with a syringe — cheapest cash route | ~$349–$499/mo | No |
Same tirzepatide in all three — the choice is about handling, cost rail, and now coverage. The full drug story is in the Zepbound review; every savings route is ranked in Zepbound coupons & savings.
Since July 1, 2026, Medicare’s GLP-1 Bridge covers Zepbound at $50/month for eligible Part D members — but the program lists only the KwikPen presentation. Single-dose pens and the LillyDirect vials people know from cash-pay are excluded. Two practical consequences: your prescription must specify the KwikPen (a vial script cannot be billed to the Bridge), and the pharmacy has to run the KwikPen NDC or the claim rejects. If you are a Medicare member currently buying vials for cash, switching presentations is the difference between ~$400/month and $50/month.
The KwikPen is simple, but two things trip people up. First, needles are not in the box — pen needles are prescribed or bought separately, and every injection needs a fresh one (reuse causes dosing errors and infection risk). Second, the 30-day clock: once a pen is in use it lives at room temperature and must be discarded 30 days after first use or after the fourth dose, whichever comes first — even if something is left inside. Never inject leftover medicine or draw it out of the pen. Unused pens stay refrigerated. The dial itself is self-limiting: turn until it stops and the correct symbol shows; the pen will not let you dial a partial or fifth dose.
The device does not change titration: 2.5 mg weekly for the first four weeks, then 5 mg, then 2.5 mg steps every four or more weeks as tolerated, up to 15 mg. One pen conveniently covers each four-week block. The honest corollary: dose changes mean a new prescription for the next strength pen — plan refills around your step-ups. Full week-by-week expectations are on the Zepbound timeline.